AI GxP validation for regulated life sciences
Medical Devices · Clinical Evaluation Reports (CER)

MDR Clinical Evaluation Report authored for a Class IIb device — every claim source-linked, submission-ready in 8 weeks

A Class IIb treatment-planning device needed an MDR-aligned Clinical Evaluation Report where every clinical claim could be walked back to its source. TraceDraft authored the CER with source-linked claims; the evidence pack travelled with the document; submission was signed off in eight weeks.

Quick chat on WhatsAppHuman review at every gatePart 11 readyISO 9001 & 27001 certified
ClientA medical device manufacturer
Size~400 employees, Class IIb device portfolio
GeographyEurope
StageCommercial
Results

What changed

TraceDraft with Cybroscape delivery leads.

See TraceDraft
8 wkTo submission-ready
100%Claims source-traceable
1 clickFrom claim to source
1st roundNB clearance target hit

Pain points before the engagement

  • MDR clinical evidence burden was overwhelming the small in-house medical writing team
  • Clinical data spanned multiple studies with different data-collection standards
  • Auditors and Notified Body reviewers were asking for traceable claims — not just cited claims
  • Prior CER drafts had gone through multiple rounds of Notified Body questions on evidence provenance
  • The submission window was fixed and non-negotiable

Problem

The device supports clinical treatment planning and had been developed over several years alongside investigator-led studies. MDR requires a CER with clinical evidence that a Notified Body reviewer can walk end-to-end. Prior CER submissions from similar devices had cycled through multiple rounds of NB questions on whether specific clinical claims were adequately supported. The team needed a CER where the answer to "where does this claim come from?" was one click, not one week.

Approach

TraceDraft ingested the source clinical data across the contributing studies. The CER template was populated section-by-section with claims linked to their source clinical facts. The review queue put source-link counts in front of the reviewers so they could focus attention on any thinly-grounded claims before submission. The evidence pack travelled with the exported CER so the Notified Body reviewer could see the traceability chain without a separate request.

Week by week

Timeline

  1. 1Source ingestion + mappingWeeks 1–2

    All contributing clinical studies ingested and mapped

  2. 2CER draftingWeeks 3–5

    Full CER drafted with source-linked claims

  3. 3Medical reviewWeeks 5–7

    Reviewers cleared thinly-grounded claims early

  4. 4Sign-off + submission packWeek 8

    Signed CER exported with evidence pack attached

Outcome

Results

  • MDR CER delivered inside the fixed 8-week window
  • Every clinical claim in the CER traceable to its source in a single click
  • Evidence pack travelled with the document — no separate provenance request from the Notified Body
  • Reviewer question count on the first NB round materially lower than the team's prior submissions
  • Template and workflow reusable for the follow-on device in the pipeline

Compliance frameworks

EU MDRIEC 6236621 CFR Part 11
The Notified Body reviewer told us this was the cleanest CER submission they had handled from a device in this class. The traceability was not a nice-to-have — it changed the reviewer conversation from "prove this" to "we can see it".
Clinical Programme LeadMedical device manufacturer

Have a similar problem?

Tell us your system and deadline. We will show you the package and the plan.

  • We reply within one business day
  • We run your inputs live on the call
  • You get a clear plan for your system
Chat on WhatsApp

Discuss a similar project

Four fields. The right specialist replies within one business day.

Your details stay private. We never share them.